Laura & Isaac Perlmutter Cancer Center

New York, New York 10016

2 studies enrolling now · 6 studies all time

What they study most

Advanced Cancer, Advanced Malignancies, Endometrial Adenocarcinoma, Malignancies, PSMA PET-Positive Castration-Resistant Prostate Cancer, Refractory Metastatic Gastric Cancer

Studies at this site

• Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC) — Recruiting now
• A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma — Recruiting now
• Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed
• Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers — Completed
• Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies — Completed
• Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study — Withdrawn before enrolling